Privia Health Group Inc (NASDAQ: PRVA) kicked off on Monday, up 4.13% from the previous trading day, before settling in for the closing price of $21.56. Over the past 52 weeks, PRVA has traded in a range of $15.92-$24.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 20.87% over the last five years. While this was happening, its average annual earnings per share was recorded -30.18%. With a float of $106.24 million, this company’s outstanding shares have now reached $118.22 million.
The firm has a total of 1102 workers. Let’s measure their productivity. In terms of profitability, gross margin is 9.47%, operating margin of 0.77%, and the pretax margin is 1.41%.
Privia Health Group Inc (PRVA) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Privia Health Group Inc is 11.47%, while institutional ownership is 97.08%. The most recent insider transaction that took place on Sep 10 ’24, was worth 2,500,127. In this transaction Chief Executive Officer of this company sold 135,142 shares at a rate of $18.50, taking the stock ownership to the 247,771 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Officer proposed sale 135,142 for $18.50, making the entire transaction worth $2,500,719.
Privia Health Group Inc (PRVA) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.15 earnings per share (EPS), lower than consensus estimate (set at 0.16) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.18% per share during the next fiscal year.
Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators
Take a look at Privia Health Group Inc’s (PRVA) current performance indicators. Last quarter, stock had a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.57. Likewise, its price to free cash flow for the trailing twelve months is 28.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.10, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.25 in one year’s time.
Technical Analysis of Privia Health Group Inc (PRVA)
Analysing the last 5-days average volume posted by the [Privia Health Group Inc, PRVA], we can find that recorded value of 0.51 million was lower than the volume posted last year of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 46.75%. Additionally, its Average True Range was 0.85.
During the past 100 days, Privia Health Group Inc’s (PRVA) raw stochastic average was set at 89.05%, which indicates a significant increase from 77.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.99% in the past 14 days, which was higher than the 41.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.03, while its 200-day Moving Average is $18.96. Now, the first resistance to watch is $22.75. This is followed by the second major resistance level at $23.05. The third major resistance level sits at $23.47. If the price goes on to break the first support level at $22.02, it is likely to go to the next support level at $21.60. Should the price break the second support level, the third support level stands at $21.30.
Privia Health Group Inc (NASDAQ: PRVA) Key Stats
The company with the Market Capitalisation of 2.69 billion has total of 120,001K Shares Outstanding. Its annual sales at the moment are 1,658 M in contrast with the sum of 23,080 K annual income. Company’s last quarter sales were recorded 437,920 K and last quarter income was 3,540 K.
